Richard A. B. Stewart
Net Worth

Last updated:

What is Richard A. B. Stewart net worth?

The estimated net worth of Dr. Richard A. B. Stewart is at least $4,223,880 as of 19 Apr 2024. He owns shares worth $27,000 as insider and has received compensation worth at least $4,196,880 in Achieve Life Sciences, Inc..

What is the salary of Richard A. B. Stewart?

Dr. Richard A. B. Stewart salary is $699,480 per year as Executive Chairman in Achieve Life Sciences, Inc..

How old is Richard A. B. Stewart?

Dr. Richard A. B. Stewart is 66 years old, born in 1959.

What stocks does Richard A. B. Stewart currently own?

As insider, Dr. Richard A. B. Stewart owns shares in one company:

Company Title Shares Price per share Total value
Achieve Life Sciences, Inc. (ACHV) Executive Chairman 10,000 $2.7 $27,000

What does Achieve Life Sciences, Inc. do?

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.

Richard A. B. Stewart insider trading

Achieve Life Sciences, Inc.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 22,500 N/A N/A
Option
Performance Restricted Stock Unit (PRSU) 22,500 N/A N/A
Purchase
Common Stock 10,000 $4.59 $45,850
Purchase
Common Stock Warrants (right to buy) 10,000 $4.91 $49,060
Option
Performance Restricted Stock Unit (PRSU) 5,000 N/A N/A
Option
Common Stock 5,000 N/A N/A
Option
Common Stock 22,500 N/A N/A
Option
Performance Restricted Stock Unit (PRSU) 22,500 N/A N/A
Option
Common Stock 5,000 N/A N/A
Option
Performance Restricted Stock Unit (PRSU) 5,000 N/A N/A
Purchase
Common Stock 17,500 N/A N/A

Achieve Life Sciences key executives

Achieve Life Sciences, Inc. executives and other stock owners filed with the SEC: